Whalegun
Lobbying

Genedx WGS's latest lobbying report covers Q2 2026, at $80K. The four quarters Q4 2025–Q3 2026 total $240K. Its first report covers Q2 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

GenedxWGS

Genedx stock page

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$240K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2022
The first quarter a report named it

Lobbying by quarter

Genedx lobbying by quarter
Genedx lobbying by quarter
QuarterAmountReports
Q2 2022$17.5K1
Q3 2022$00
Q4 2022$00
Q1 2023$00
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$80K1
Q3 2025$80K1
Q4 2025$80K1
Q1 2026$80K1
Q2 2026$80K1
Q3 2026$00

By issue

  • Health issues$200K · 5 reports
  • Medicare and Medicaid$200K · 5 reports
  • Medical research and clinical labs$17.5K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Food & Drug Administration (FDA)2 reports

Firms it paid

Firm
Red+blue Strategies$400K5 quarters
Ipolicy Solutions$17.5K1 quarters

Former officials lobbying for it

Former position
ANNABELL MCWHERTER STOKESCounsel, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2020) Law Clerk, U.S. Senate Committee on Veterans Affairs, Senator Johnny Isakson (2018-2018)Q2 2026
JENNIFER RACHEL LEIBFellow, Senate Health, Education, Labor, and Pensions CommitteeQ2 2022

Lobbying reports

Filed by
09/10for Q3Michael Best StrategiesUnder $5,000
07/17for Q2Red+blue Strategies$80K
04/20for Q1Red+blue Strategies$80K
01/20for Q4 2025Red+blue Strategies$80K
25/10/11for Q3 2025Red+blue Strategies$80K
25/07/17for Q2 2025Red+blue Strategies$80K
25/07/17for Q2 2025Red+blue Strategies$30K
25/04/21for Q2 2025Red+blue StrategiesUnder $5,000
23/05/15for Q2 2022Ipolicy Solutions$17.5K